without sodium bicarbonate (n = 592) | with sodium bicarbonate (n = 592) | p value | |
---|---|---|---|
Female (%) | 185 (31.2) | 193 (32.6) | 0.663 |
Age (mean (SD)) | 67.93 (13.54) | 67.53 (12.25) | 0.592 |
Cause of CKD (%) | 0.149 | ||
Diabetes Mellitus | 275 (46.5) | 256 (43.2) | |
Nephrosclerosis | 150 (25.3) | 138 (23.3) | |
Others, unknown | 167 (28.2) | 198 (33.4) | |
Past history | |||
Diabetes Mellitus (%) | 309 (52.2) | 291 (49.2) | 0.323 |
CAD (%) | 102 (17.3) | 93 (15.7) | 0.506 |
PAD (%) | 35 (5.9) | 24 (4.1) | 0.182 |
Atrial fibrillation (%) | 46 (7.8) | 26 (4.4) | 0.020 |
Admission of HF (%) | 125 (21.1) | 103 (17.4) | 0.122 |
Aortic Dissection (%) | 35 (5.9) | 29 (4.9) | 0.516 |
Malignancy (%) | 64 (10.8) | 71 (12.0) | 0.583 |
Stroke (%) | 70 (11.8) | 41 (6.9) | 0.005 |
X-ray | |||
CTR (mean (SD)) | 55.14 (7.02) | 54.95 (7.31) | 0.648 |
Cardiac ultrasonography | |||
EF (mean (SD)) | 61.18 (11.75) | 61.44 (11.79) | 0.734 |
Administration | |||
Spironolactone (%) | 24 (4.1) | 33 (5.6) | 0.277 |
DRI (%) | 20 (3.4) | 31 (5.2) | 0.152 |
CCB (%) | 472 (79.7) | 498 (84.1) | 0.059 |
Loop (%) | 417 (70.4) | 396 (66.9) | 0.210 |
Thiazide (%) | 151 (25.5) | 122 (20.6) | 0.053 |
ARBACEI (%) | 366 (61.8) | 370 (62.5) | 0.857 |
BB (%) | 220 (37.2) | 199 (33.6) | 0.224 |
Statin (%) | 238 (40.2) | 250 (42.2) | 0.516 |
VDRA (%) | 143 (24.2) | 204 (34.5) | < 0.001 |
Anti Platelet (%) | 197 (33.3) | 168 (28.4) | 0.078 |
ESA (%) | 557 (94.1) | 558 (94.3) | 1.000 |
Laboratory data | |||
WBC (/uL) (mean (SD)) | 6555 (2711) | 6344 (2607) | 0.173 |
Hb (g/dL) (mean (SD)) | 9.42 (1.52) | 9.46 (1.41) | 0.638 |
Plt (10,000/uL) (mean (SD)) | 18.00 (7.29) | 17.84 (6.70) | 0.706 |
Alb (g/dL) (mean (SD)) | 3.20 (0.58) | 3.24 (0.60) | 0.203 |
BUN (mg/dL) (mean (SD)) | 94.56 (29.33) | 88.00 (27.03) | < 0.001 |
Cr (mg/dL) (mean (SD)) | 8.92 (2.93) | 9.08 (2.89) | 0.346 |
eGFR (mL/min/1.73m2) (mean (SD)) | 5.34 (1.74) | 5.22 (1.90) | 0.289 |
Na (mEq/L) (mean (SD)) | 137.9 (4.2) | 138.1 (4.4) | 0.546 |
K (mEq/L) (mean (SD)) | 4.51 (0.83) | 4.53 (0.80) | 0.784 |
Adjusted Ca (mg/dL) (mean (SD)) | 8.67 (1.02) | 8.56 (1.04) | 0.064 |
P (mg/dL) (mean (SD)) | 6.38 (1.89) | 6.24 (1.70) | 0.174 |
Mg (mg/dL) (mean (SD)) | 2.18 (0.48) | 2.14 (0.46) | 0.177 |
UA (mg/dL) (mean (SD)) | 9.05 (2.39) | 8.50 (2.19) | < 0.001 |
LDL-C (mg/dL) (mean (SD)) | 88 (32) | 90 (35) | 0.241 |
CRP (mg/dL) (mean (SD)) | 1.54 (3.67) | 1.75 (4.41) | 0.397 |
β2MG (ug/dL) (mean (SD)) | 19.37 (5.58) | 19.15 (5.84) | 0.623 |
TSAT (%) (mean (SD)) | 27.73 (16.77) | 26.15 (15.72) | 0.136 |
Ferritin (ng/dL) (median [IQR]) | 129.00 [68.00, 227.25] | 112.00 [56.15, 197.50] | 0.006 |
pH (mean (SD)) | 7.34 (0.08) | 7.35 (0.07) | 0.012 |
HCO3− (mEql/L) (mean (SD)) | 19.46 (5.07) | 20.37 (4.36) | 0.003 |
Other | |||
HF symptoms at admission (%) | 168 (28.6) | 165 (27.9) | 0.840 |
Outcome | |||
CVD-related death (%) | 35 (6.0) | 31 (5.3) | 0.714 |
infection-related death (%) | 25 (4.2) | 17 (2.9) | 0.271 |
All-cause death (%) | 112 (18.9) | 83 (14.0) | 0.028 |